SLC16A1 and neoplasm: In addition, M2 macrophages participate in tumor progression through the secretion of cytokines and exosomes.[41, 42] Our findings suggest that the methylation‐deficient variant of MCT1 inhibits subcutaneous tumor growth, which may be partially attributed to lactate‐mediated macrophage.